![]() |
市場調查報告書
商品編碼
1492546
食道支架市場:按類型、材料、應用和最終用戶分類 - 全球預測 2024-2030Esophageal Stents Market by Type (Biodegradable Stents, Self-expandable Metal Stents, Self-expandable Plastic Stents), Material (Nitinol, Silicone, Stainless Steel), Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年食道支架市場規模為1.504億美元,預計2024年將達到1.5947億美元,2030年將達2.301億美元,複合年成長率為6.26%。
食道支架是一種由金屬或塑膠製成的管狀裝置,用於打開食道狹窄(將食物從喉嚨輸送到胃的管道)。這些支架主要用於治療食道狹窄或阻塞,這些狹窄或阻塞通常由癌症、胃食道逆流症 (GERD) 或其他疾病引起。由於食道癌盛行率不斷增加、支架技術的進步提高了患者的舒適度和治療結果,以及與傳統手術相比支架置入的微創性,食道支架的使用正在擴大。儘管有這些好處,食道支架可能會導致併發症,例如遷移(支架從其原始位置移動)或因腫瘤生長穿過支架而再次閉塞。此外,患者可能會感到不適和疼痛,尤其是吞嚥時。需要不斷改進支架設計來解決這些問題。例如,開發隨著時間的推移而溶解的生物分解性支架,減少額外手術的需要,或在支架上塗上藥物以對抗腫瘤生長。然而,隨著對支架材料和塗層的研究不斷深入,以提高與身體的相容性並減少併發症,市場將繼續成長。還有可能利用 3D 列印技術的進步,根據患者的個人醫療需求客製化支架。
主要市場統計 | |
---|---|
基準年[2023] | 1.504 億美元 |
預測年份 [2024] | 1.5947億美元 |
預測年份 [2030] | 2.301 億美元 |
複合年成長率(%) | 6.26% |
區域洞察
在美國和加拿大,先進醫療技術的採用率很高,包括使用食道支架來治療食道癌和良性食道狹窄。該市場得到了成熟的醫療基礎設施和有利的報銷政策的支持。至於歐洲、中東和非洲地區,歐洲在市場成熟度方面處於領先地位,特別是在德國、法國和英國等國家,醫療費用的上升和食道疾病的流行正在推動市場的發展。中東和非洲正在逐漸迎頭趕上,但市場成長因不同程度的醫療保健和財務限制而受到阻礙。亞太地區顯示出巨大的成長潛力,特別是中國、日本和印度等國家。醫療保健標準的提高、中階的壯大和醫療旅遊業的擴大推動了這一成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估食道支架市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對食道支架市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對當前食道支架市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[189 Pages Report] The Esophageal Stents Market size was estimated at USD 150.40 million in 2023 and expected to reach USD 159.47 million in 2024, at a CAGR 6.26% to reach USD 230.10 million by 2030.
Esophageal stents are tubular devices made of metal or plastic that are used to open narrowed areas of the esophagus, the tube that carries food from the throat to the stomach. These stents are primarily used to treat esophageal strictures or blockages, often caused by cancer, gastroesophageal reflux disease (GERD), or other medical conditions. The growing prevalence of esophageal cancer advances in stent technology that improves patient comfort and outcomes and the minimally invasive nature of stent placement compared to traditional surgical procedures have expanded the use of esophageal stents. Despite their benefits, esophageal stents can cause complications, such as migration, where the stent moves from its original position or re-obstruction caused by tumor growth through the stent. Additionally, patients may experience discomfort or pain, particularly when swallowing. Addressing these issues involves continuous improvements in stent design, such as developing biodegradable stents that dissolve over time, reducing the need for additional procedures, or coating stents with drugs to help combat tumor growth. Nevertheless, increasing research into stent materials and coatings that enhance compatibility with the body and reduce complications provides added growth for the market. There is also potential in customizing stents for patients based on personalized medical needs, leveraging advances in 3D printing technology.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 150.40 million |
Estimated Year [2024] | USD 159.47 million |
Forecast Year [2030] | USD 230.10 million |
CAGR (%) | 6.26% |
Regional Insights
In the Americas, U.S., and Canada, there is a high adoption rate of advanced medical technologies, which includes the use of esophageal stents for conditions including esophageal cancer and benign esophageal strictures. The market is supported by well-established healthcare infrastructure and favorable reimbursement policies. Moving to EMEA, Europe leads in terms of market maturity, especially in countries such as Germany, France, and the UK, which are driven by increasing healthcare expenditure and the prevalence of esophageal diseases. The Middle East and Africa are gradually catching up, although the market growth here is tempered by varying levels of healthcare access and economic constraints. The Asia Pacific region showcases significant growth potential, particularly in countries such as China, Japan, and India. This growth is spurred by rising healthcare standards, an increasing middle-class population, and growing medical tourism.
Market Insights
The market dynamics represent an ever-changing landscape of the Esophageal Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Esophageal Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Esophageal Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Olympus Corporation Advances in Gastrointestinal Treatment Through Acquisition of Taewoong Medical
Olympus Corporation finalized its acquisition of Taewoong Medical Co., Ltd., a South Korean firm renowned for its advanced gastrointestinal metallic stents. This strategic move, valued at approximately USD 370 million, integrates Taewoong Medical into Olympus' Therapeutic Solutions Division, enhancing its capabilities in the GI EndoTherapy arena. This acquisition fortifies Olympus's portfolio in providing comprehensive GI solutions and aims to elevate patient care standards globally. [Published On: 2024-01-24]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Esophageal Stents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Esophageal Stents Market, highlighting leading vendors and their innovative profiles. These include Advin Healthcare Private Limited, Boston Scientific Corporation, Changzhou Health Microport Medical Device Co., LTD., Cook Group Incorporated, ELLA-CS, s.r.o., ENDO-FLEX GmbH. by Medi-Globe Group, Leufen Medical by bess AG., M.I.TECH., Medorah Meditek Pvt. Ltd., Medtronic plc, Merit Medical Systems, Inc., MICRO-TECH (Nanjing) Co., Ltd., Micro-Tech Endoscopy, Mitra Industries Pvt. Ltd., Olympus Corporation, S&G Biotech Inc., TAEWOONG MEDICAL Co., Ltd, and W. L. Gore & Associates, Inc..
Market Segmentation & Coverage